Summary:
Click image to enlargeA compensated Phase 1 study that will examine the safetiness of a new malaria vaccine.
Qualified Participants Must:
• Be between the ages of 18-55 years old
• Be willing and able to participate in all planned study visits for the duration of the study
• Be in good health
• Be of low cardiac risk
• Agree not to travel to places where there is malaria during the time of the study
• Be a male or non-pregnant, Non-breastfeeding female